What is the official website of Solara Active Pharma Sciences ?

The official website of Solara Active Pharma Sciences is http://www.solara.co.in.

What is Solara Active Pharma Sciences's cybersecurity risk score?

Solara Active Pharma Sciences has an AI-generated cybersecurity risk score of 758 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Solara Active Pharma Sciences experienced?

According to Rankiteo, Solara Active Pharma Sciences currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Solara Active Pharma Sciences been affected by any supply chain cyber incidents ?

According to Rankiteo, Solara Active Pharma Sciences has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Solara Active Pharma Sciences have SOC 2 Type 1 certification ?

According to Rankiteo, Solara Active Pharma Sciences is not certified under SOC 2 Type 1.

Does Solara Active Pharma Sciences have SOC 2 Type 2 certification ?

According to Rankiteo, Solara Active Pharma Sciences does not hold a SOC 2 Type 2 certification.

Does Solara Active Pharma Sciences comply with GDPR ?

According to Rankiteo, Solara Active Pharma Sciences is not listed as GDPR compliant.

Does Solara Active Pharma Sciences have PCI DSS certification ?

According to Rankiteo, Solara Active Pharma Sciences does not currently maintain PCI DSS compliance.

Does Solara Active Pharma Sciences comply with HIPAA ?

According to Rankiteo, Solara Active Pharma Sciences is not compliant with HIPAA regulations.

Does Solara Active Pharma Sciences have ISO 27001 certification ?

According to Rankiteo,Solara Active Pharma Sciences is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Solara Active Pharma Sciences operate in ?

Solara Active Pharma Sciences operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does Solara Active Pharma Sciences have ?

Solara Active Pharma Sciences employs approximately 1,135 people worldwide.

Does Solara Active Pharma Sciences own any subsidiaries ?

Solara Active Pharma Sciences presently has no subsidiaries across any sectors.

How many LinkedIn followers does Solara Active Pharma Sciences have ?

Solara Active Pharma Sciences's official LinkedIn profile has approximately 20,499 followers.

What is the NAICS classification code for Solara Active Pharma Sciences ?

Solara Active Pharma Sciences is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does Solara Active Pharma Sciences have a Crunchbase profile ?

Yes, Solara Active Pharma Sciences has an official profile on Crunchbase, which can be accessed here: https://www.crunchbase.com/organization/solara-active-pharma.

Does Solara Active Pharma Sciences have a LinkedIn profile ?

Yes, Solara Active Pharma Sciences maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/solara-active-pharma-sciences.

How many cybersecurity incidents has Solara Active Pharma Sciences experienced ?

As of September 16, 2026, Rankiteo reports that Solara Active Pharma Sciences has not experienced any cybersecurity incidents.

How many peer or competitor companies does Solara Active Pharma Sciences have ?

Solara Active Pharma Sciences has an estimated 5,763 peer or competitor companies worldwide.

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

SAPS

Boost Score +25 with badge (5 left)

758

/1000

Fair

783

/1000

Fair

Solara Active Pharma Sciences Vendor Cyber Rating & Cyber Score

solara.co.in

cb in

Add Your Compliance Badge

Solara Active Pharma Sciences is a young, dynamic, entrepreneurial and customer oriented API manufacturer. We have a legacy of over three decades and trace our origins to the API expertise of Strides Shasun Ltd. and the technical knowhow of human API business from Sequent Scientific Ltd. We are poised to bridge the industry gap by delivering value based products while maintaining focus on the customer needs. We have 140+ scientists working at our two R&D Centers and 4 API manufacturing facilities armed with global approvals and 2 dedicated R&D facilities. OUR VISION We will be amongst the Top 10 Pure-Play Global Active Pharmaceutical Ingredients Company that builds significant value for our partners, stakeholders and shareholders,

SAPS

Solara Active Pharma Sciences CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

SAPS Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for SAPS

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Solara Active Pharma Sciences in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Solara Active Pharma Sciences in 2026.

Incident Types SAPS vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Solara Active Pharma Sciences in 2026.

Incident History - SAPS (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Solara Active Pharma Sciences Subsidiaries

SAPS

Pharmaceutical Manufacturing

Website: http://www.solara.co.in

Company Size: 1,135

StridesPharmaceutical Manufacturing

Stelis BiopharmaPharmaceutical Manufacturing

ArcolabBusiness Consulting and Services

Naari Pharma Pvt Ltd.Pharmaceutical Manufacturing

Strides Pharma CanadaPharmaceutical Manufacturing

InstaPillPharmaceutical Manufacturing

Loading…

Solara Active Pharma Sciences Similar Companies

Zydus Group

zyduslife.com

The Zydus Group with an overarching purpose of empowering people with freedom to live healthier and more fulfilled lives, is an innovative, global life-sciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies. The group employs over 27000 people worldwide and is driven by its mission to unlock new possibilities in life-sciences through quality healthcare solutions that impact lives. The group aspires to transform lives through pathbreaking discoveries.

MACLEODS PHARMACEUTICALS LTD.

macleodspharma.com

A vertically integrated, Global Pharmaceutical Company. Established in 1989, we are engaged in developing, manufacturing, and marketing a wide range of formulations across several major therapeutic areas including anti-infectives, cardiovascular, anti-diabetic, dermatology, and hormone treatment. We develop, manufacture, and globally distribute a broad range of pharmaceutical products across therapies in multiple dosage forms such as solid orals, liquid orals, topical formulations, injectables (Dry Powder) metered dose inhalers and dry powder inhalers. Our Vision To be a leading global pharmaceutical company by providing high quality, affordable and innovative therapeutic solutions for patients with diverse medical needs. Our Mission To contribute towards improving patients’ quality of life across the globe, by providing effective and accessible medicines.

Takeda

cb takeda.com

We strive to transform lives. While the science we advance is constantly evolving, our core purpose is enduring. For more than two centuries, our values have guided us to do what’s right for patients and for society. We know that changing lives requires us to do things differently. We start by listening to and addressing what really matters to patients, the people who love them, and those in the healthcare system who provide care. And that’s what inspires us all to be bold, push boundaries and set new standards that open up greater opportunities. Read our community guidelines: https://takeda.info/communityguidelines

Servier

servier.com

Founded to serve health 70 years ago, Servier is a global pharmaceutical group governed by a non-profit Foundation that aspires to make a meaningful social impact for patients and for a sustainable world. The Group’s unique governance model preserves its independence and means it can fully serve its vocation of being committed to therapeutic progress to serve patient needs while adopting a long-term vision. Its employees are fully committed to this shared vocation, which serves as a source of inspiration every day. A world leader in cardiometabolism and venous diseases, Servier has made a major shift into oncology, which represents a new pillar of strategic growth. The Group devotes close to 70% of its R&D budget to this field, with the ambition of becoming a focused and innovative player in the development of treatments targeting rare cancers. Neurology will constitute a future growth driver. Servier is focusing on a limited number of diseases in this area where accurate patient profiling makes it possible to offer a targeted therapeutic response through precision medicine. To promote widespread access to quality care at a lower cost, the Group also offers a range of quality generic drugs covering most pathologies, leveraging well-known brands in France, and Eastern Europe. In all these areas, the Group takes patient considerations into account at every stage of the medicine life cycle. Headquartered in France, Servier relies on committed teams and strong geographical footprint; its medicines are available in close to 140 countries. In 2023/2024, the Group achieved sales revenue of €5.9 billion and EBITDA of €1.3 billion in 2024 (22.2%). Today, the Group employs over 22,000 people worldwide. -- To report a suspected adverse event with a Servier drug, please visit servier.com

SUN PHARMA

sunpharma.com

Sun Pharma is the world's fourth-largest speciality generic pharmaceutical company and No. 1 in India. We provide high-quality, affordable medicines trusted by customers and patients in over 100 countries. Sun Pharma's global presence is supported by more than 40 manufacturing facilities spread across 5 continents, R&D centres across the globe, and a multicultural workforce comprising over 50 nationalities. Sun Pharma fosters excellence through innovation supported by strong R&D capabilities comprising around 3,000 scientists and R&D investments of over 6-8% of annual revenues. At Sun, our people are our greatest asset. Ours has never been a story of individual brilliance but of cultivating a culture of realising collective potential. In our journey, everyone is enabled to take charge in an environment that offers limitless growth opportunities. We are with you every step of the way, so you can shine for years to come. With the launch of our Employee Value Proposition (EVP), we define our promise to ‘Create Your Own Sunshine'—driven by the three pillars of Better Every Day, Take Charge, and Thrive Together. These pillars drive progress at Sun so that people can achieve what they would have thought impossible. Learn more about our EVP here: https://sunpharma.com/careers/

Hikma Pharmaceuticals

cb hikma.com

For almost 50 years, we’ve been creating high-quality medicines and making them accessible to the people who need them. We are a trusted, reliable partner and dependable source of over 800* high-quality generic, specialty and branded pharmaceutical products that hospitals, physicians and pharmacists need to treat their patients across North America, MENA and Europe. We have 29 manufacturing plants, 3 R&D hubs and c9,500 employees worldwide. *As of December 2025 Subscribe to our channel on YouTube https://youtube.com/@hikmapharmaceuticals5668 For all product information and enquiries, please contact us at [email protected]

Novo Nordisk

cb novonordisk.com

We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 68,800 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com. This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to block and remove those that are off-topic, abusive or intended to spam. Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in: https://www.novonordisk.com/contact-us/find-local-information.html For other customer complaints, please contact us here: https://www.novonordisk.com/contact-us.html Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed. Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users. Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html

UCB

cb ucb.com

At UCB, we believe everyone deserves to live the best life they can - as free as possible from the challenges and uncertainty of disease. Our purpose is to support people living with severe central nervous system and immunological conditions by delivering meaningful solutions that go beyond medicine. We are driven by the experiences of patients and caregivers, and inspired to pursue innovations that create real value - not just in clinical outcomes, but in everyday moments, dreams pursued, and simple pleasures enjoyed. Our ambition is to unlock transformative science and technologies that respond to unmet needs and elevate lives. From our headquarters in Belgium to nearly 40 countries around the world, we nurture a culture of respect and care. By listening deeply and collaborating across borders and disciplines, we enable cutting-edge research shaped by patients’ needs. Through strong connections with healthcare professionals, partners, and communities, we strive to make a lasting impact - today and into the future. We're inspired by patients, driven by science.

Grifols

cb linktr.ee

Grifols is a global healthcare company founded in Barcelona in 1909 committed to improving the health and well-being of people all over the world. A leader in essential plasma-derived medicines and transfusion medicine, we develop, produce and provide innovative healthcare services and solutions in more than 110 countries. Patient needs and our ever-growing knowledge of many chronic, rare and prevalent diseases, sometimes life-threatening, drive our innovation in plasma-based therapies and other biopharmaceuticals to enhance quality of life. Grifols is focused on treating conditions across a broad range of therapeutic areas: immunology, hepatology and intensive care, pulmonology, hematology, neurology and infectious diseases. With a workforce of over 23,000 employees in more than 30 countries and regions, we are committed to a sustainable business model that sets the standard for continuous innovation, quality, safety and ethical leadership in the industry. Our work has a positive social and economic impact in the countries where we operate, creating jobs and generating wealth. People are at the heart of what we do, and we strive to create an inclusive, diverse, fair and equal society. Maintaining and promoting a workforce that reflects this reality leads to enhanced professional relationships and helps us to give our best to patients, donors and customers. In 2024, Grifols was named one of TIME’s ‘World’s Best Companies’ for the second year in a row, reaffirming our commitment to excellence. We were also recognized by Forbes as one of the "Best Employers for Women 2023," reflecting our dedication to fostering an inclusive and supportive workplace for all. To maintain a positive community and overall respectful communication, please keep our community guidelines in mind.

Loading…

NEWS

Solara Active Pharma Sciences CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

April 24, 2018 07:00 AM

Strides Shasun to divest API arm to Solara for Rs 131 cr

India Business News: New Delhi, Apr 24 () Drug firm Strides Shasun today said its board has approved a proposal to divest its entire...

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-85893

SUMMARY

Use after free in Microsoft Edge (Chromium-based) allows an unauthorized attacker to elevate privileges over a network.

Published

Date2026-09-15

Updated

Date2026-09-15

RISK INFORMATION (Score: 8.8)

cvss3

Base Score: 8.8

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H

Impact Score

5.9

Exploitability

2.8

REFERENCES

https://msrc.microsoft.com/update-guide/vulnerability/CVE-2026-85893

CVE-2026-69486

SUMMARY

Heap-based buffer overflow in Microsoft Edge (Chromium-based) allows an unauthorized attacker to execute code over a network.

Published

Date2026-09-15

Updated

Date2026-09-15

RISK INFORMATION (Score: 8.8)

cvss3

Base Score: 8.8

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H

Impact Score

5.9

Exploitability

2.8

REFERENCES

https://msrc.microsoft.com/update-guide/vulnerability/CVE-2026-69486

CVE-2025-11395

SUMMARY

A flaw was found in Podman. If an attacker can pass a crafted tar archive to the `podman load` command, they can create files on the host machine with the privileges of the user running Podman.

Published

Date2026-09-15

Updated

Date2026-09-15

RISK INFORMATION (Score: 5.5)

cvss3

Base Score: 5.5

Complexity: LOW

CVSS:3.1/AV:A/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L

Impact Score

3.4

Exploitability

2.1

REFERENCES

CVE-2026-92259

SUMMARY

Integer overflow or wraparound vulnerability in Samsung Opensource Escargot allows attackers with write access to the bytecode-cache directory to cause a heap-based buffer overflow and denial of service via a crafted cache file. This issue affects Escargot: ac94df78493ee6fede286620d94f724e46b4d238.

Published

Date2026-09-15

Updated

Date2026-09-15

RISK INFORMATION (Score: 5.5)

cvss3

Base Score: 5.5

Complexity: LOW

CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:H

Impact Score

3.6

Exploitability

1.8

REFERENCES

https://github.com/Samsung/escargot/pull/1650

CVE-2026-92257

SUMMARY

Netcore NR255-V version 1.5.130703 contains a stored cross-site scripting vulnerability in L7 content management pages that use eval() sinks, affecting the call board text and policy group handling components. Attackers can inject persistent script payloads through these pages to have malicious code executed in the context of other users viewing the affected content.

Published

Date2026-09-15

Updated

Date2026-09-15

RISK INFORMATION (Score: 5.4)

cvss3

Base Score: 5.4

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N

cvss4

Base Score: 5.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:P/VC:L/VI:L/VA:N/SC:L/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

2.7

Exploitability

2.3

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…

Badge your company to reduce your risk score and your cyber insurance costs!

Trusted by insurers. Chosen by leaders.

Solara Active Pharma Sciences Vendor Cyber Rating & Cyber Score

SAPS A.I CyberSecurity Scoring

Solara Active Pharma Sciences CyberSecurity News & History

SAPS Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for SAPS

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types SAPS vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - SAPS (X = Date, Y = Severity)

Solara Active Pharma Sciences Subsidiaries

SAPS

Solara Active Pharma Sciences Similar Companies

Zydus Group

MACLEODS PHARMACEUTICALS LTD.

Takeda

Servier

SUN PHARMA

Hikma Pharmaceuticals

Novo Nordisk

UCB

Grifols

Solara Active Pharma Sciences CyberSecurity News

Strides Shasun to divest API arm to Solara for Rs 131 cr

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo

Solara Active Pharma Sciences CyberSecurity News & History

SAPS Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for SAPS

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types SAPS vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - SAPS (X = Date, Y = Severity)

Solara Active Pharma Sciences Subsidiaries

SAPS

Solara Active Pharma Sciences Similar Companies

Zydus Group

MACLEODS PHARMACEUTICALS LTD.

Takeda

Servier

SUN PHARMA

Hikma Pharmaceuticals

Novo Nordisk

UCB

Grifols

Solara Active Pharma Sciences CyberSecurity News

Strides Shasun to divest API arm to Solara for Rs 131 cr

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo